These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 17159771)

  • 41. Human hepatic and renal microsomes, cytochromes P450 1A1/2, NADPH:cytochrome P450 reductase and prostaglandin H synthase mediate the formation of aristolochic acid-DNA adducts found in patients with urothelial cancer.
    Stiborová M; Frei E; Hodek P; Wiessler M; Schmeiser HH
    Int J Cancer; 2005 Jan; 113(2):189-97. PubMed ID: 15386410
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Stereo- and regioselectivity account for the diversity of dehydroepiandrosterone (DHEA) metabolites produced by liver microsomal cytochromes P450.
    Miller KK; Cai J; Ripp SL; Pierce WM; Rushmore TH; Prough RA
    Drug Metab Dispos; 2004 Mar; 32(3):305-13. PubMed ID: 14977864
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Human enzymes involved in the metabolic activation of carcinogenic aristolochic acids: evidence for reductive activation by cytochromes P450 1A1 and 1A2.
    Stiborová M; Frei E; Wiessler M; Schmeiser HH
    Chem Res Toxicol; 2001 Aug; 14(8):1128-37. PubMed ID: 11511187
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Modulation of CYP1A1-mediated oxidation of carcinogenic azo dye Sudan I and its binding to DNA by cytochrome b5.
    Stiborová M; Martínek V; Schmeiser HH; Frei E
    Neuro Endocrinol Lett; 2006 Dec; 27 Suppl 2():35-9. PubMed ID: 17159775
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Sudan I is a potential carcinogen for humans: evidence for its metabolic activation and detoxication by human recombinant cytochrome P450 1A1 and liver microsomes.
    Stiborová M; Martínek V; Rýdlová H; Hodek P; Frei E
    Cancer Res; 2002 Oct; 62(20):5678-84. PubMed ID: 12384524
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Biochemical characteristics of purified beef liver NADPH-cytochrome P450 reductase.
    Arinç E; Celik H
    J Biochem Mol Toxicol; 2002; 16(6):286-97. PubMed ID: 12481304
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effects of natural polyphenols on aflatoxin B1 activation in a reconstituted microsomal monooxygenase system.
    Firozi PF; Bhattacharya RK
    J Biochem Toxicol; 1995 Feb; 10(1):25-31. PubMed ID: 7595929
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Evidence for requirement of NADPH-cytochrome P450 oxidoreductase in the microsomal NADPH-sterol Delta7-reductase system.
    Nishino H; Ishibashi T
    Arch Biochem Biophys; 2000 Feb; 374(2):293-8. PubMed ID: 10666310
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Ellipticine and benzo(a)pyrene increase their own metabolic activation via modulation of expression and enzymatic activity of cytochromes P450 1A1 and 1A2.
    Aimová D; Poljaková J; Kotrbová V; Moserová M; Frei E; Arlt VM; Stiborová M
    Interdiscip Toxicol; 2008 Sep; 1(2):160-8. PubMed ID: 21218107
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Lack of mechanism-based inactivation of rat hepatic microsomal cytochromes P450 by doxorubicin.
    Di Re J; Lee C; Riddick DS
    Can J Physiol Pharmacol; 1999 Aug; 77(8):589-97. PubMed ID: 10543722
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Human cytochrome-P450 enzymes metabolize N-(2-methoxyphenyl)hydroxylamine, a metabolite of the carcinogens o-anisidine and o-nitroanisole, thereby dictating its genotoxicity.
    Naiman K; Martínková M; Schmeiser HH; Frei E; Stiborová M
    Mutat Res; 2011 Dec; 726(2):160-8. PubMed ID: 21946300
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Non-specific inhibition of human cytochrome P450-catalyzed reactions by hemin.
    Kim EY; Kim JS; Kim MY; Koh WS; Guengerich FP; Yun CH
    Toxicol Lett; 2004 Nov; 153(2):239-46. PubMed ID: 15451555
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Oxidative detoxication of carcinogenic 2-nitroanisole by human, rat and rabbit cytochrome P450.
    Dracínska H; Miksanová M; Svobodová M; Smrcek S; Frei E; Schmeiser HH; Stiborová M
    Neuro Endocrinol Lett; 2006 Dec; 27 Suppl 2():9-13. PubMed ID: 17159769
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Ellipticine, 9-hydroxyellipticine, and 9-hydroxyellipiticinum: some biochemical properties of possible pharmacologic significance.
    Paoletti C; Auclair C; Lesca P; Tocanne JF; Malvy C; Pinto M
    Cancer Treat Rep; 1981; 65 Suppl 3():107-18. PubMed ID: 7049365
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Formation of DNA adducts by ellipticine and its micellar form in rats - a comparative study.
    Stiborova M; Manhartova Z; Hodek P; Adam V; Kizek R; Frei E
    Sensors (Basel); 2014 Dec; 14(12):22982-97. PubMed ID: 25479328
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Relationship between content and activity of cytochrome P450 and induction of heterocyclic amine DNA adducts in human liver samples in vivo and in vitro.
    Baranczewski P; Möller L
    Cancer Epidemiol Biomarkers Prev; 2004 Jun; 13(6):1071-8. PubMed ID: 15184267
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Metabolic activation of adriamycin by NADPH-cytochrome P450 reductase; overview of its biological and biochemical effects.
    Bartoszek A
    Acta Biochim Pol; 2002; 49(2):323-31. PubMed ID: 12362973
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Development of a novel cytochrome p450 bioaffinity detection system coupled online to gradient reversed-phase high-performance liquid chromatography.
    Kool J; van Liempd SM; Ramautar R; Schenk T; Meerman JH; Irth H; Commandeur JN; Vermeulen NP
    J Biomol Screen; 2005 Aug; 10(5):427-36. PubMed ID: 16093552
    [TBL] [Abstract][Full Text] [Related]  

  • 59. AFM study of membrane proteins, cytochrome P450 2B4, and NADPH-cytochrome P450 reductase and their complex formation.
    Kiselyova OI; Yaminsky IV; Ivanov YD; Kanaeva IP; Kuznetsov VY; Archakov AI
    Arch Biochem Biophys; 1999 Nov; 371(1):1-7. PubMed ID: 10525282
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Role of cytochromes P450 1A1/2 in detoxication and activation of carcinogenic aristolochic acid I: studies with the hepatic NADPH:cytochrome P450 reductase null (HRN) mouse model.
    Levová K; Moserová M; Kotrbová V; Sulc M; Henderson CJ; Wolf CR; Phillips DH; Frei E; Schmeiser HH; Mares J; Arlt VM; Stiborová M
    Toxicol Sci; 2011 May; 121(1):43-56. PubMed ID: 21362632
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.